FDA Green Lights Generic Namenda for Dementia
FDA approves new drug application for generic Namenda from Upsher-Smith.
Namenda is an NMDA (N-methyl-D-aspartate) inhibitor indicated for the treatment of moderate to severe dementia of the Alzheimer's type. It is presumed to work as a low to moderate affinity uncompetitive (open-channel) NMDA receptor antagonist which binds preferentially to the NMDA receptor-operated cation channels.
Memantine HCl Tablets will be available in 5mg and 10mg strengths.
For more information call (888) 650-3789 or visit Upsher-Smith.com.